Expanded Access Programs (EAPs) provide patients access to investigational drugs outside of the clinical trial setting. These programs provide promising new medicines to patients suffering from cancer or rare diseases who have no other [...]
In recent years, industry has been looking for ways to modernize the traditional clinical trial model. As such, companies are now being encouraged to try methodologies and strategies that will streamline processes and introduce [...]
After Right to Try legislation was passed in the US earlier this year, many believe that desperate patients will now find it easier to try investigational products outside of the clinical trial setting. However, like [...]
